METHOD FOR LASER THERAPY OF PATIENTS WITH ATOPIC DERMATITIS Russian patent published in 2015 - IPC A61N5/67 

FIELD: medicine.

SUBSTANCE: method involves intravenous laser blood irradiation (ILBI) at a power of 1-2 mW. The ILBI uses low-intensity continuous laser light at alternating wave lengths 365-405 nm (UVA spectrum) and 520-525 nm (green spectrum) with varying exposure during 12 daily sessions. The exposure conforms to the following schedule: 1^st session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 2^nd session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 3^rd session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 4^th session - 520-525 nm, power 1-2 mW, exposure 7 minutes; 5^th session - 365-405 nm, power 1-2 mW, exposure 3 minutes; 6^th session - 520-525 nm, power 1-2 mW, exposure 10 minutes; 7^th session - 365-405 nm, power 1-2 mW, exposure 3 minutes; 8^th session - 520-525 nm, power 1-2 mW, exposure 10 minutes; 9^th session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 10^th session - 520-525 nm, power 1-2 mW, exposure 7 minutes; 11^th session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 12^th session - 520-525 nm, power 1-2 mW, exposure 5 minutes.

EFFECT: method enables improving the treatment quality and efficacy in the patients with atopic dermatitis by the integrated effect on different links of the disease process.

2 tbl